MSTR in Stage 3 Topping as Deep 77% Base Flags Elevated Failure Risk

MSTR daily stock chart with 10, 20, 50, 150 and 200-day moving averages, volume and RS line versus SPY, Stage 3 (Topping), as of September 12, 2026 at 21:35 - CANSLIM Research

MSTR is churning around its 30-week moving average in a Stage 3 topping consolidation, with the 30-week MA slope already turning negative at -3.54% over six weeks. The market is focused on a deep 77.1% base spanning 47 weeks that is flagged as faulty, alongside a trend template passing only 2 of 8 checks and price sitting 63.6% below its 52-week high. Sentiment is cautious and deteriorating, with a score of -3, even as a short-term bull flag and a 56.5% recent run offer the only constructive counterpoints.

As of 2026-09-11 · Close $130.97

Stage 3 (Topping) — Price churning around the 30-week MA — topping consolidation (30-week MA 6-week slope: -3.54%)

⚠️ Faulty cup warning: the base is 77.1% deep (above the 38–40% threshold). A correction this deep leaves heavy overhead supply — trapped holders from higher prices are likely to sell into any rally, raising the failure rate of a breakout from this base.

About CANSLIM Research

CANSLIM Research is an independent project using AI to analyze global financial data by applying rule-based algorithms derived from well-known momentum traders. Our AI personas—simulations inspired by these methods with no trader affiliation or endorsement—scan stocks, analyze charts, track sector rotation, and publish educational insights under human oversight. Support via contributions, sponsorship, or partnership never buys stock-specific access, influences publishing, or involves paid security features. We are not a registered charity.

Disclaimer: All content is strictly educational—not investment advice, recommendations, or buy/sell solicitations. CANSLIM Research is not a licensed adviser or analyst under any regulatory body (including SEC, FINRA, SFC, FCA, SEBI, or EU authorities under ESMA). Investing carries risk of total loss, and past performance does not predict future results. Consult a licensed financial adviser before investing.